SMITH & NEPHEW PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 960.2 GBX | -0.19% |
|
-1.13% | -10.97% |
| Apr. 11 | UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates | MT |
| Apr. 11 | Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal | MT |
Financials (USD)
| Sales 2024 * | 5.83B | Sales 2025 * | 6.13B | Capitalization | 10.42B |
|---|---|---|---|---|---|
| Net income 2024 * | 552M | Net income 2025 * | 703M | EV / Sales 2024 * | 2.23 x |
| Net Debt 2024 * | 2.55B | Net Debt 2025 * | 2.23B | EV / Sales 2025 * | 2.06 x |
| P/E ratio 2024 * |
20.4
x | P/E ratio 2025 * |
15.4
x | Employees | 18,452 |
| Yield 2024 * |
3.21% | Yield 2025 * |
3.59% | Free-Float | 99.1% |
More Fundamentals
* Assessed data
More news
Latest transcript on Smith & Nephew Plc
More recommendations
More press releases
More news
| 1 day | -0.19% | ||
| 1 week | -1.13% | ||
| Current month | -3.17% | ||
| 1 month | -9.67% | ||
| 3 months | -11.26% | ||
| 6 months | +1.20% | ||
| Current year | -10.97% |
1 week
946.00
991.00
1 month
946.001 059.50
Current year
946.001 181.50
1 year
887.001 316.75
3 years
887.001 601.50
5 years
887.002 023.00
10 years
871.002 023.00
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 22-03-31 |
John Rogers
DFI | Director of Finance/CFO | 56 | Nov. 30 |
Alison Parkes
CMP | Compliance Officer | - | 99-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 65 | 17-09-30 |
Jeremy Maiden
BRD | Director/Board Member | 62 | 23-09-13 |
Rupert Soames
CHM | Chairman | 63 | 23-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.16% | 16 M€ | -7.36% | ||
| 0.52% | 11 M€ | +0.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 960.2 | -0.19% | 2,567,634 |
| 24-04-16 | 962 | +0.35% | 4,653,030 |
| 24-04-15 | 958.6 | -0.27% | 2,903,863 |
| 24-04-12 | 961.2 | -1.96% | 4,082,042 |
| 24-04-11 | 980.4 | +0.95% | 2,608,204 |
Delayed Quote London S.E., April 17, 2024 at 11:35 am EDT
More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
11.95
USD
Average target price
16.48
USD
Spread / Average Target
+37.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.97% | 10.43B | |
| +12.21% | 128B | |
| +0.66% | 8.86B | |
| +19.70% | 6.71B | |
| +21.89% | 4.79B | |
| +7.99% | 3.43B | |
| +0.39% | 3.1B | |
| -14.51% | 2.01B | |
| -12.07% | 1.94B | |
| -26.41% | 1.65B |
- Stock Market
- Equities
- SN. Stock
